Congressional Research Service Reports - 43,127 Matching Results
Search Results
- HIV/AIDS International Programs: FY2003 Request and FY2002 Spending
- Supplemental Appropriations legislation for FY2002, currently before Congress, could increase spending for international HIV/AIDS programs beyond the amounts currently projected.
- HIV/AIDS International Programs: FY2003 Request and FY2002 Spending
- No Description Available.
- HIV/AIDS International Programs: FY2002 Spending and FY2003 Outlook
- No Description Available.
- HIV/AIDS International Programs: FY2002 Spending and FY2003 Outlook
- No Description Available.
- HIV/AIDS International Programs: FY2002 Spending and FY2003 Outlook
- This report provides FY2002 spending and FY2003 outlook of HIV/AIDS International programs.
- HIV/AIDS International Programs: Appropriations, FY2003-FY2005
- This report discusses about US International HIV/AIDS Programs, HIV/AIDS in the foreign operations Appropriations, Labor/HHS Appropriations and other appropriations.
- HIV/AIDS International Programs: Appropriations, FY2003-FY2005
- The Administration's FY2005 request for international HIV/AIDS, tuberculosis, and malaria programs totals about $2.8 billion, as compared with $2.4 billion appropriated for FY2004. The FY2005 request includes a large increase for the bilateral Global AIDS Initiative, headquartered at the Department of State, while the request for the Global Fund to Fight AIDS, Tuberculosis, and Malaria is $200 million, compared with $546.7 million appropriated in FY2004.
- HIV/AIDS International Programs: Appropriations, FY2003-FY2005
- The Administration's FY2005 request for international HIV/AIDS, tuberculosis, and malaria programs totals about $2.8 billion, as compared with $2.4 billion appropriated for FY2004. The FY2005 request includes a large increase for the bilateral Global AIDS Initiative, headquartered at the Department of State, while the request for the Global Fund to Fight AIDS, Tuberculosis, and Malaria is $200 million, compared with $546.7 million appropriated in FY2004.
- HIV/AIDS International Programs: Appropriations, FY2003-FY2005
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2005
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- This is a report on the administration's requests for international HIV/AIDS programs in the fiscal year 2004.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- No Description Available.
- HIV/AIDS International Programs: Appropriations, FY2002-FY2004
- This is a report on the international programs for HIV/AIDS and the budgets around it during the fiscal year 2002-2004.
- Human Cloning
- This report provides information about the Human Cloning where a human embryo produced via cloning involves the process called somatic cell nuclear transfer. The nuclear of the egg is removed and replaced with a mature body cell.
- Background and Legal Issues Related to Stem Cell Research
- In August 2001, President Bush announced that federal funds, with certain restrictions, may be used to conduct research on human embryonic stem cells. Federal research is limited to “the more than 60” existing stem cell lines that were derived (1) with the informed consent of the donors; (2) from excess embryos created solely for reproductive purposes; and (3) without any financial inducements to the donors. No federal funds may be used for the derivation or use of stem cell lines derived from newly destroyed embryos; the creation of any human embryos for research purposes; or cloning of human embryos for any purposes.
- Federal and State Causes of Action Against Health Plans Under S. 1052 and S. 889
- No Description Available.
- A Brief Summary of the Medical Privacy Rule
- This report provides a brief overview of the modified medical privacy rule, “Standards for the Privacy of Individually Identifiable Health Information”(“privacy rule”) published on August 14, 2002 by the Department of Health and Human Services (HHS). The privacy regulation creates a new federal floor of privacy protections while leaving in place more protective state rules or practices. The rule establishes a set of basic consumer protections and a series of regulatory permissions for uses and disclosures of protected health information.
- A Brief Summary of the Medical Privacy Rule
- This report provides a brief overview of the recently modified medical privacy rule, “Standards for the Privacy of Individually Identifiable Health Information”(“privacy rule”) published on August 14, 2002 by the Department of Health and Human Services (HHS). The privacy rule went into effect April 14, 2001, with compliance required by April 2003 for most entities. The regulation creates a new federal floor of privacy protections while leaving in place more protective state rules or practices. The rule establishes a set of basic consumer protections and a series of regulatory permissions for uses and disclosures of protected health information.
- A Brief Summary of the Medical Privacy Rule
- On March 27, 2002 the Department of Health and Human Services (HHS) published its proposed changes to the medical privacy regulations issued by the Clinton Administration under the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”). HHS is accepting comments on the proposed changes until April 26, 2002. This report provides an overview of the final rule for “Standards for the Privacy of Individually Identifiable Health Information” ( “privacy rule”) that went into effect on April 14, 2001, and an overview of the Bush Administration’s proposed changes to the privacy regulation.
- A Brief Summary of the HIPAA Medical Privacy Rule
- This report provides a brief overview of the modified HIPAA Privacy rule, “Standards for the Privacy of Individually Identifiable Health Information” (“privacy rule”) published on August 14, 2002 by the Department of Health and Human Services (HHS).
- Endocrine Disruption: An Introduction
- Exposure to certain chemicals in the environment could disrupt the hormone systems of animals and humans, according to some scientists who are concerned about potential risks to public health and ecosystems. Congress has mandated chemical screening to assess the potential of pesticides and drinking water contaminants to influence the normal functions of female, male and thyroid hormones. As conflicting scientific evidence accumluates on the hormone disruption hypothesis, legislators may consider proposals to increase or decrease funding for the endocrine disruption screening program, or to expand its requirements to include additional chemicals or hormone functions.
- The Prescription Drug Import Provisions of the FY2001 Agriculture Appropriations Act, P.L. 106-387
- No Description Available.
- Assisted Suicide and the Controlled Substances Act: Legal Issues Associated with the Proposed Pain Relief Promotion Act
- The Pain Relief Promotion Act, as proposed in the 106th Congress, provided that the Attorney General, in determining whether the registration of a doctor for the administration of controlled substances is in the public interest, should give no force and effect to state law authorizing or permitting assisted suicide or euthanasia. This language would appear to have been designed to abrogate the legal reasoning set forth by the Attorney General in a press release regarding the application of the Controlled Substances Act to acts of physician-assisted suicide. It would not, however, appear to have required the Attorney General to revoke such registrations; nor would it have criminalized assisted suicide or euthanasia. This report will be updated as congressional action warrants.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Labeling of Genetically Modified Foods
- This report focuses on views surrounding the labeling of genetically modified (GM) foods in consideration of the Food and Drug Administration's (FDA) draft guidance for industry on voluntary efforts to label GM foods in 2001 following its GM food labeling policy of May 1992.
- Labeling of Genetically Modified Foods
- Congressional interest in the labeling of genetically modified foods (GM foods) has been rising. So far, two bills have been introduced to mandate that all foods from genetically modified crops (GM crops) be labeled as such. The Food and Drug Administration (FDA) issued its current GM food labeling policy in May 1992. At that time, the agency determined that it would regulate GM foods no differently than foods created by conventional means because FDA considered them substantially equivalent to traditional foods and decided that no special label would be needed. In the intervening period, extensive public debate surrounding the genetic modification of foods has led some consumers to call for labeling of such products. A label would permit customers to choose to avoid purchasing or consuming them. Others oppose labeling because to make such labels "truthful and not misleading" all commodities would need to be segregated and tested, and the label would not have room to impart information that could not be distributed in other ways. The federal government's role in regulating these foods is explained in CRS report RL30198, Food Biotechnology in the United States: Science, Regulation, and Issues. This report focuses specifically on views surrounding the labeling of GM foods. It will be updated periodically as new legislative proposals are introduced.
- Medical Malpractice Liability Reform: Legal Issues and Fifty-State Survey of Caps on Punitive Damages and Noneconomic Damages
- No Description Available.
- Medical Malpractice Liability Reform: Legal Issues and Fifty-State Survey of Caps on Punitive Damages and Noneconomic Damages
- No Description Available.
- Medical Malpractice Liability Reform: Legal Issues and Fifty-State Survey of Caps on Punitive Damages and Noneconomic Damages
- No Description Available.
- Medical Malpractice Liability Reform: Legal Issues and Fifty-State Survey of Caps on Punitive Damages and Noneconomic Damages
- No Description Available.
- Medical Malpractice Liability Reform: Legal Issues and Fifty-State Survey of Caps on Punitive Damages and Noneconomic Damages
- No Description Available.
- Medical Malpractice Liability Reform: Legal Issues and Fifty-State Survey of Caps on Punitive Damages and Noneconomic Damages
- No Description Available.
- Human Cloning
- This report provides information about the Human Cloning where a human embryo produced via cloning involves the process called somatic cell nuclear transfer. The nuclear of the egg is removed and replaced with a mature body cell.
- Human Cloning
- This report provides information about the Human Cloning where a human embryo produced via cloning involves the process called somatic cell nuclear transfer. The nuclear of the egg is removed and replaced with a mature body cell.
- Human Cloning
- This report provides information about the Human Cloning where a human embryo produced via cloning involves the process called somatic cell nuclear transfer. The nuclear of the egg is removed and replaced with a mature body cell.
- Human Cloning
- This report provides information about the Human Cloning where a human embryo produced via cloning involves the process called somatic cell nuclear transfer. The nuclear of the egg is removed and replaced with a mature body cell.
- Human Cloning
- This report provides information about the Human Cloning where a human embryo produced via cloning involves the process called somatic cell nuclear transfer. The nuclear of the egg is removed and replaced with a mature body cell.
- Human Cloning
- This report provides information about the Human Cloning where a human embryo produced via cloning involves the process called somatic cell nuclear transfer. The nuclear of the egg is removed and replaced with a mature body cell.
- Cloning: A Select Chronology, 1997-2003
- This report includes a selected chronology of the events surrounding and following the cloning of a sheep from a single adult sheep cell by Scottish scientists, which was announced in February 1997. The project was cosponsored by PPL Therapeutics, Edinburgh, Scotland, which has applied for patents for the techniques used. This chronology also addresses subsequent reports of other cloning experiments, including the first one using human cells. Information on presidential actions and legislative activities related to the ethical and moral issues surrounding cloning is provided, as well as relevant Web sites.
- Cloning: A Select Chronology, 1997-2003
- This report includes a selected chronology of the events surrounding and following the cloning of a sheep from a single adult sheep cell by Scottish scientists, which was announced in February 1997. The project was cosponsored by PPL Therapeutics, Edinburgh, Scotland, which has applied for patents for the techniques used. This chronology also addresses subsequent reports of other cloning experiments, including the first one using human cells. Information on presidential actions and legislative activities related to the ethical and moral issues surrounding cloning is provided, as well as relevant Web sites.
- Cloning: A Select Chronology, 1997-2003
- This report includes a selected chronology of the events surrounding and following the cloning of a sheep from a single adult sheep cell by Scottish scientists, which was announced in February 1997. The project was cosponsored by PPL Therapeutics, Edinburgh, Scotland, which has applied for patents for the techniques used. This chronology also addresses subsequent reports of other cloning experiments, including the first one using human cells. Information on presidential actions and legislative activities related to the ethical and moral issues surrounding cloning is provided, as well as relevant Web sites.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.